Brought to you by:
The top 10 most popular Vascular Specialist stories of January 2023
In January 2023, most popular among the Vascular Specialist readers were several stories from the recent Southern Association for Vascular Surgery meeting, including a report of data shared to demonstrate the benefits of vascular involvement in non-vascular-led cases; an update on the use of the Human Acellular…
New book penned by vascular icon charts career in surgery, revolutionary spirit
A new memoir penned by former Society for Vascular Surgery (SVS) President and vascular surgery leader Frank J. Veith, MD, which touches on a lifetime of service to the specialty and tackles some of its most monumental and controversial moments,…
Medtronic announces first enrollment in head-to-head global randomized trial evaluating durability of EVAR
Medtronic has announced the first patient enrollment in the ADVANCE trial, a head-to-head randomized controlled trial of two leading aortic stent graft systems, the Medtronic Endurant II/IIs stent graft system and Gore Excluder abdominal aortic aneurysm (AAA) device family systems.…
How a multidisciplinary team meets the complex challenges of fixing failed EVARs
This advertorial is sponsored by Tampa General Hospital. The Aortic Disease Program at Tampa General Hospital’s Heart & Vascular Institute is no stranger to the challenges of complex care. Situated in the population center of Tampa, Florida, in the nation’s…
Endologix receives FDA approval of PMA supplement for AFX2 system
Endologix recently announced that it has received Food and Drug Administration (FDA) approval for a premarket approval (PMA) supplement relating to the AFX2 system. According to a company press release, Endologix received approval to include an updated warning and the…
Eastern Vascular gathering challenged to forge next generation of evolution
Evolution was the core theme of the Presidential Address Robert Rhee, MD, delivered from the Eastern Vascular Society (EVS) annual meeting stage in Philadelphia (Sept. 29–Oct. 1). “Let’s Evolve,” it was entitled. But, Rhee told those gathered, the society lays…
The top 10 most popular Vascular Specialist stories of October 2022
The most-read Vascular Specialist stories in October covered an investigation of thoracic endovascular aortic repair (TEVAR) timing presented at the Eastern Vascular Society (EVS) meeting in Philadelphia (Sept. 29–Oct. 1); the editor-in-chief’s open letter to the National Rifle Association; tips on…
The top 10 most popular Vascular Specialist stories of September 2022
September’s top stories featured news of a trial to evaluate women’s experience of early endovascular aneurysm repair, and of a special women-focused edition of the Annals of Vascular Surgery. A guest commentary on the importance of advocacy in vascular surgery…
CX Aortic Vienna: Onus on industry to meet clinician desire for devices that function, adapt in long term
The need for vascular companies to home in on developing longer-lasting devices—perhaps even ones that adapt over time to match patients’ changing anatomies—was underscored as part of the Juxtarenal session on day two of the CX Aortic Vienna 2022 Digital Edition (Oct. 24–26).…
Why 25 years of patient-centered innovation really matters
This advertorial is sponsored by Gore. One mainstay endovascular aneurysm repair (EVAR) device is celebrating not just a quarter century of being commercially available, but the innovation it has inspired along the way. Michel Makaroun, MD, and Willy Davison, PhD,…